Katsounas Antonios, Canbay Ali
Department for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Magdeburg, Magdeburg, Germany.
Visc Med. 2018 Aug;34(4):283-289. doi: 10.1159/000492088. Epub 2018 Aug 8.
Decompensated cirrhosis is characterized by high hospitalization rates and costs, frequent readmissions, and poor short-term survival. Patients admitted to the hospital with acute variceal bleeding and/or hepatic encephalopathy and/or renal dysfunction are at serious risk for developing infection and/or sepsis; in turn, this renders them highly susceptible to the development of multi-system organ failure. The lack of standardized intensive care unit management protocols in patients with cirrhosis along with only few data reports from longitudinal clinical trials makes it difficult for hepatologists and critical care specialists to provide uniform evidence for clinical practice that could safely consolidate favorable outcomes such as lower hospitalization rates and/or mortality. Based on a rigorous online search of the scientific literature as well as a longtime clinical experience of the authors in the field of hepatology and critical care medicine, this work represents a focused effort to elucidate the specific bio-morbidity of advanced liver diseases in relation to the aforementioned challenges in clinical management. Further meta-analyses and/or systematic reviews are needed to enable clinicians to develop more effective strategies to bridge patients with decompensated liver disease to recompensation or liver transplantation.
失代偿期肝硬化的特点是住院率高、费用高、频繁再入院以及短期生存率低。因急性静脉曲张出血和/或肝性脑病和/或肾功能不全入院的患者发生感染和/或脓毒症的风险很高;反过来,这使他们极易发生多系统器官衰竭。肝硬化患者缺乏标准化的重症监护病房管理方案,同时纵向临床试验的数据报告很少,这使得肝病学家和重症监护专家难以提供统一的临床实践证据,以安全巩固诸如降低住院率和/或死亡率等良好结果。基于对科学文献的严格在线搜索以及作者在肝病学和重症医学领域的长期临床经验,这项工作旨在集中阐明晚期肝病的特定生物发病率与上述临床管理挑战之间的关系。需要进一步的荟萃分析和/或系统评价,以使临床医生能够制定更有效的策略,将失代偿性肝病患者过渡到代偿或肝移植。